Synthesis and Evaluation of Biological and Antioxidant Activity for Mefenamic Drug Derivativesof Some New Heterocyclic Compounds
- سال انتشار: 1402
- محل انتشار: فصلنامه کاتالیزور، دوره: 2، شماره: 1
- کد COI اختصاصی: JR_CIC-2-1_001
- زبان مقاله: انگلیسی
- تعداد مشاهده: 80
نویسندگان
Department of Chemistry, Faculty of science, University Babylon, Babylon, Iraq
Department of Chemistry, Faculty of science, University Babylon, Babylon, Iraq
Department of Chemistry, Faculty of science, University Babylon, Babylon, Iraq
Department of Chemistry, College of science ,University of Babylon , Babylon, Iraq
چکیده
New heterocyclic derivatives were created in this investigation.The most readily accessible Mefenamic acid (M) was combined with thionyl chloride to produce (M۱ compound).After treating the (M۱) compound with hydrazinecarboxamide to obtain the (M۲) derivative, the compound (M۲) was subjected to a ring closer reaction with NaOH solution to obtain the ۱,۲,۴-triazole-۳-ol ring compound (M۳). Compound (M) was reacted with phenyl hydrazine hydrate to produce (M۴), and then a ring closer reaction was performed in basic medium with carbon disulfide and hydrazine hydrate to produce (M۵).The chemical (M۱) was reacted with ۳-aminopropanoic acid to produce (M۶).To obtain the oxazin ring, (M۷) molecule was synthesized by treating (M۶) compound with benzaldehyde in the presence of acetic anhydride (M۷ compound). The biological and antioxidant activity of the prepared compounds (M۱-M۷) was studied by (DPPH) method, and the results were good compared to the standard ascorbic acid.کلیدواژه ها
Mefenamic acid, Hydrazinecarboxamide, Phenylhydrazine, Oxazin, Antioxidant activityاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.